NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. (“ESSA Pharma Inc.” or the “Company”) (NASDAQ:EPIX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who were adversely affected by alleged securities fraud between December 12, 2023 and October 31, 2024. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=132365&wire=3
EPIX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) masofaniten in combination with …
